Product Code: ETC069982 | Publication Date: Jun 2021 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Contract Cell and Gene Therapy Manufacturing market in Mexico are playing a pivotal role in advancing the field of personalized medicine. As cell and gene therapies hold promise for treating various diseases, contract manufacturing organizations are crucial for scaling up production and ensuring regulatory compliance. This market is characterized by collaboration between biopharmaceutical companies and manufacturing partners, contributing to the growth of the cell and gene therapy sector in Mexico.
The Mexican Contract Cell and Gene Therapy Manufacturing market is being propelled by advancements in biotechnology and a growing demand for personalized medicine. With increasing investment in research and development, Mexico is emerging as a key player in the global biopharmaceutical manufacturing landscape.
The Contract Cell and Gene Therapy Manufacturing sector in Mexico confronts challenges related to infrastructure and technology. Insufficient manufacturing facilities with state-of-the-art equipment pose a bottleneck for companies looking to scale up production. Moreover, the shortage of skilled professionals adept at cell and gene therapy manufacturing processes is a critical hindrance. This shortage extends across various disciplines, including bioprocessing, quality control, and regulatory affairs, thereby hampering the industry`s potential growth.
The Contract Cell and Gene Therapy Manufacturing market in Mexico are witnessing robust growth as pharmaceutical companies leverage external manufacturing expertise. Government initiatives to facilitate a conducive environment for contract manufacturing have attracted both domestic and international players. This approach not only accelerates the development of novel therapies but also positions Mexico as a key player in the global cell and gene therapy manufacturing landscape.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Contract Cell and Gene Therapy Manufacturing Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Mexico Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2021 & 2031F |
3.6 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Mexico Contract Cell and Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mexico Contract Cell and Gene Therapy Manufacturing Market Trends |
6 Mexico Contract Cell and Gene Therapy Manufacturing Market, By Types |
6.1 Mexico Contract Cell and Gene Therapy Manufacturing Market, By Vector |
6.1.1 Overview and Analysis |
6.1.2 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2018 - 2031F |
6.1.3 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2018 - 2031F |
6.1.4 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2018 - 2031F |
6.2 Mexico Contract Cell and Gene Therapy Manufacturing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2018 - 2031F |
6.2.3 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2018 - 2031F |
6.2.4 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2018 - 2031F |
6.2.5 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2018 - 2031F |
7 Mexico Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Mexico Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Mexico Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries |
8 Mexico Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators |
9 Mexico Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Mexico Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2021 & 2031F |
9.2 Mexico Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Mexico Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Mexico Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Mexico Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |